Boothbay Fund Management’s Bioventus BVS Stock Holding History

Boothbay Fund Management’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,567	Closed	-$115K	–	2278
2026 Q1	$115K	Sell	12,567 -47,138	-79%	-$395K	﹤0.01%	1864
2025 Q4	$444K	Sell	59,705 -57,149	-49%	-$411K	0.01%	1211
2025 Q3	$782K	Buy	116,854 +33,117	+40%	+$230K	0.01%	937
2025 Q2	$554K	Buy	+83,737	New	+$594K	0.01%	874
2024 Q4	–	Sell	-156,307	Closed	-$1.87M	–	1524
2024 Q3	$1.87M	Buy	156,307 +16,307	+12%	+$141K	0.04%	540
2024 Q2	$805K	Buy	+140,000	New	+$768K	0.02%	804
2024 Q1	–	Sell	-14,219	Closed	-$74.9K	–	1599
2023 Q4	$74.9K	Buy	+14,219	New	+$56.3K	﹤0.01%	1473

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boothbay Fund Management's BVS Position: Q2 2026 in Review

Boothbay Fund Management sold out of Bioventus (BVS) in Q2 2026, closing a stake of 12,567 shares — an estimated $115K sold.

Boothbay Fund Management first reported a position in BVS in Q4 2023 and held it in 7 quarters. The position peaked at $1.87M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

Boothbay Fund Management reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
Boothbay Fund Management sold 12,567 Bioventus shares in Q2 2026, an estimated $115K.
Boothbay Fund Management first reported a position in Bioventus in Q4 2023 and held it in 7 quarters.
Boothbay Fund Management's Bioventus position peaked at $1.87M in Q3 2024.
157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.